Tg Therapeutics reported $0 in Loan Capital for its second fiscal quarter of 2021.

Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
Loan Capital Change
Acceleron Pharma XLRN:US $ 0M 0M
Amgen AMGN:US $ 33291M 4833M
Ardelyx ARDX:US $ 7.03M 8.1M
Arena Pharmaceuticals ARNA:US $ 37.48M 1.3M
Arrowhead Research ARWR:US $ 0 0
Bayer BAYN:GR € 36974M 310M
Biogen BIIB:US $ 6272.3M 996.9M
Corcept Therapeutics CORT:US $ 0M 0M
Curis CRIS:US $ 0M 0M
Infinity Pharmaceuticals INFI:US $ 0M 0M
Karyopharm Therapeutics KPTI:US $ 301.57M 195K
Novartis NOVN:VX SF 24715M 1776M
Novavax NVAX:US $ 323.1M 8.84M
Ptc Therapeutics PTCT:US $ 972.21M 143.17M
Puma Biotechnology PBYI:US $ 96.8M 28.1M
Regeneron Pharmaceuticals REGN:US $ 1979.6M 0.4M
Spectrum Pharmaceuticals SPPI:US $ 0M 0M
Verastem VSTM:US $ 0.24M 20.08M
Vertex Pharmaceuticals VRTX:US $ 513.26M 11.67M